Fatty acid synthase (Fasn), the major enzyme responsible for fatty acid biosynthesis, are found to correlate with poor prognosis in some cancer types 18, while in CRC patients Fasn expression on clinical outcome varied with geography and ethnic. The gene discussed is FASN; the disease is colorectal carcinoma.